Convergence and Equity in Biomedical Engineering: A Multi-Method Synthesis of Emerging Biomedical Innovations

This paper presents a focused multi-method synthesis of contemporary biomedical engineering innovations, examining how equity, affordability, and material–biological interactions shape the development of more accessible and responsible medical technologies. The analysis centers on three interconnected domains: equity-centered design for AI-driven medical devices, cost-effective 3D-printed implants for resource-constrained settings, and polysaccharide hydrogel degradation in relation to immune responses. We conducted a systematic synthesis combining literature review, regulatory document analysis, targeted economic evidence assessment, and scoping review methods to identify convergent patterns across these domains. Our findings reveal that equity centered design frameworks, incorporating stakeholder participation and lifecycle surveillance, are better suited than traditional human factors engineering to mitigate algorithmic bias in AI driven Software as a Medical Device. However, the evidence base remains largely conceptual, with limited quantitative head to head comparisons. For 3D printed implants, patient specific solutions demonstrate clinical promise in cranioplasty and complex orthopaedics, with ultra low cost polymethyl methacrylate cranioplasty reported at approximately forty US dollars per implant in Pakistan. Nevertheless, direct evidence on formal cost effectiveness metrics in low resource settings is scarce. The scoping review on polysaccharide hydrogels indicates that faster degrading formulations often coincide with stronger early inflammatory signaling, while controlled degradation supports a more tempered foreign body response however, a valid Spearman correlation could not be computed due to inconsistent numeric degradation values and non standardized immune measures across studies. The novelty of this work lies in its systematic integration of findings across these disparate domains, revealing that biomedical engineering innovation is increasingly driven by convergence across materials science, digital manufacturing, software integration, and human centered design. This synthesis informs future device development pathways, regulatory frameworks, and educational strategies, particularly regarding equity centered design and cost effective manufacturing in resource constrained environments.